Home/Filings/4/0001193125-25-320941
4//SEC Filing

Bensen Daniel 4

Accession 0001193125-25-320941

CIK 0001863127other

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 4:30 PM ET

Size

4.9 KB

Accession

0001193125-25-320941

Insider Transaction Report

Form 4
Period: 2025-12-12
Bensen Daniel
Chief Discovery Officer
Transactions
  • Sale

    Common Stock

    2025-12-12$22.64/sh8,000$181,159162,981 total
Footnotes (2)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024.
  • [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $22.06 to $23.03. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Documents

1 file

Issuer

Tyra Biosciences, Inc.

CIK 0001863127

Entity typeother

Related Parties

1
  • filerCIK 0001880946

Filing Metadata

Form type
4
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:30 PM ET
Size
4.9 KB